title: A comparison of the efficacy and pharmacokinetics of ivermectin after spring and autumn treatments against Cyathostominae in horses.
abstract: The aim of the present study was to determine the efficacy of ivermectin against Cyathostominae infections and to describe the drug's pharmacokinetic parameters during two seasonal deworming treatments in horses. The study was performed on warm-blooded mares aged 3-12 years weighing 450-550 kg. A single bolus of an oral paste formulation of ivermectin was administered at a dose of 0.2 mg/kg BW in spring and autumn. Fecal samples were tested before treatment and 1, 2, 3, 4, 6, 10, 20, 30, 40, 50, 60, 75 days after treatment. Ivermectin concentrations in blood samples collected before treatment, 0.5, 1, 2, 3, 4, 6, 12, 24, 36 and 48 hours after treatment, and 3, 4, 6, 8, 10, 15, 20, 25, 30, 40, 50, 60 and 75 days after drug administration were determined by high pressure liquid chromatography. Drug absorption was significantly (p<0.05) slower (tmax: 21.89±11.43 h) in autumn than in spring (tmax: 9.78±8.97 h). Maximum concentrations (Cmax) of ivermectin in the blood plasma of individual horses (8.40-43.08 ng/ml) were observed 2-24 h after drug administration during the spring treatment and 2-36 h (6.43-24.86 ng/ml) after administration during the autumn treatment. Significantly higher (p<0.05) ivermectin concentrations were found during the first 4 hours after administration in spring in comparison with those determined after the autumn treatment. The administration of the recommended dose of ivermectin resulted in 100% elimination of parasitic eggs from feces in spring and autumn treatment.
authors.forename: R
authors.initials: R
authors.lastname: Sokół
authors.forename: M
authors.initials: M
authors.lastname: Raś-Noryńska
authors.forename: M
authors.initials: M
authors.lastname: Michalczyk
authors.forename: A
authors.initials: A
authors.lastname: Jasiecka
authors.forename: H
authors.initials: H
authors.lastname: Ziółkowski
authors.forename: J
authors.initials: J
authors.lastname: Jaroszewski
mesh_terms: D000818:Animals; D000977:Antiparasitic Agents / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D019540:Area Under Curve; D005260:Female; D006207:Half-Life; D006734:Horse Diseases / Q000188:drug therapy / Q000469:parasitology*; D006736:Horses; D007559:Ivermectin / Q000097:blood / Q000493:pharmacokinetics / Q000627:therapeutic use*; D012621:Seasons; D017183:Strongylida / Q000145:classification*; D017206:Strongylida Infections / Q000188:drug therapy / Q000662:veterinary*
chemical_list: D000977:Antiparasitic Agents; D007559:Ivermectin